
Helaina
Helaina makes effera™, the first bio-identical human lactoferrin — a better-absorbed protein supporting gut, immune, and women's health.
$45M Series B+ ·
Source: Femtech Insider
Latest round on record: Series B+, March 2026, amount undisclosed.
All 2 rounds ↓Signals
Website registeredMar 23, 2019 (7 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | undisclosed | — | fundraisingfox.com | |
| Series B+ | $45M | — | Femtech Insider |
Timeline
- Website created
Founders and team
LK
Laura Katz Founder of Helainasource: myhelaina.com
Companies like Helaina
AAll GSeries B+ · Aug 2026FFormo$61M Series B+ · Oct 2024
IIngrediomeFFreya BiosciencesSeries A · Nov 2024
PPrickly Pear Health$600K Pre Seed · Mar 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/helaina (get a free API key).